Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Start CC audio at 5:00 minutes: Management feels their stock
View:
Post by subaru1i on Mar 27, 2024 3:59pm

Start CC audio at 5:00 minutes: Management feels their stock

price is UNDERVALUED....I have known that for a LONG time but WHY is management high lighting this now?  It's a no brainer with the DEA rescheduling any day now and LABS is the ONLY FDA approved pharmaceutical company in NORTH AMERICA capable of supplying cannbinoid pharmaceutical molecules for pharmaceutical appications.  

PIDDUCK BROUGHT THIS PUBLICLY FOR A REASON.
Comment by mdjbrown on Mar 27, 2024 4:04pm
s1i, heres an out of the box thought - Would it be surprising to hear STADA takes a run at Medipharm Multi billion dollar company getting into medicinal CBD sales in a country about to let loose in 4 days.
Comment by okgonow on Mar 27, 2024 4:08pm
it would be a cash deal cause im pretty sure they are a private company 
Comment by mdjbrown on Mar 27, 2024 4:14pm
Agree okgonow Very interesting that all of a sudden Medipharm execs are making sure everyone knows the company share price is undervalued, when previously they didnt seem too concerned.  That is until they loaded up with RSU's. Coincidence?
Comment by subaru1i on Mar 27, 2024 4:18pm
STADA could try that but you don't get over 20 clinical trials funded by a global pharma partner and turn your back on the global pharma partner that you worked with...that imho would be a legal mess.   Still sticking to my gun....Pfizer all the way.   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities